416
Views
50
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Strategy for Predicting Future Exacerbation of Asthma Using a Combination of the Asthma Control Test and Lung Function Test

, M.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D. show all
Pages 677-682 | Published online: 09 Sep 2009

References

  • Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(suppl)S94–S138
  • Nathan R A, Sorkness C A, Kosinski M, Schatz M, Li J T, Marcus P, Murray J J, Pendergraft T B. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59–65
  • Tomita K, Hanaki K, Hasegawa Y, Watanabe M, Sano H, Igishi T, Burioka N, Hitsuda Y, Horimukai K, Fukutani K, Sugimoto Y, Yamamoto M, Kato K, Ikeda T, Konishi T, Tokuyasu H, Kawasaki Y, Yajima H, Sejima H, Isobe T, Takabatake T, Shimizu E; San-in Asthma Research Group. Underrecognition of the severity of asthma and undertreatment of asthma in a rural area of Japan. J Asthma 2005; 42: 689–696
  • Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI), Bethesda (MD) 2006; 339
  • Bateman E D, Hurd S S, Barnes P J, Bousquet J, Drazen J M, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen S E, Pizzichini E, Sullivan S D, Wenzel S E, Zar H J. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143–178
  • McCoy K, Shade D M, Irvin C G, Mastronarde J G, Hanania N A, Castro M, Anthonisen NR; American Lung Association Asthma Clinical Research Centers. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006; 118: 1226–1233
  • Adams R J, Smith B J, Ruffin R E. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55: 566–573
  • Kitch B T, Paltiel A D, Kuntz K M, Dockery D W, Schouten J P, Weiss S T, Fuhlbrigge A L. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest 2004; 126: 1875–1882
  • Miller M K, Lee J H, Miller D P, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007; 101: 481–489
  • Cowie R L, Underwood M F, Revitt S G, Field S K. Predicting emergency department utilization in adults with asthma: a cohort study. J Asthma 2001; 38: 179–184
  • Adams R J, Smith B J, Ruffin R E. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55: 566–573
  • Eisner M D, Katz P P, Yelin E H, Shiboski S C, Blanc P D. Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res 2001; 2: 53–60
  • Federico M J, Wamboldt F S, Carter R, Mansell A, Wamboldt M Z. History of serious asthma exacerbations should be included in guidelines of asthma severity. J Allergy Clin Immunol 2007; 119: 50–56
  • Green R H, Brighting C E, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw A J, Pavord I D. Asthma exacerbations and sputum eosinophil counts in randomized controlled trial. Lancet 2002; 360: 1715–1721
  • Harkins M S, Fiato K L, Iwamoto G K. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41: 471–476
  • Gelb A F, Taylor C F, Shinar C M, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129: 1492–1499
  • Pauwels R A, Lofdahl C G, Postma D S, Tattersfield A E, O'Byrne P, Barnes P J, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405–1411
  • American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912–930
  • Brieman L, Friedman J H, Olshen R A, Stone C J. Classification and Regression Trees. Wadsworth, Belmont, CA 1984
  • Bateman E D, Boushey H A, Bousquet J, Busse W W, Clark T J, Pauwels R A, Pedersen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836–844
  • Osborne M L, Pedula K L, O'Hollaren M, Ettinger K M, Stibolt T, Buist A S, Vollmer W M. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest 2007; 132: 1151–1161
  • Payne D N, Adcock I M, Wilson N M, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Repir Crit Care Med 2001; 164: 1376–1381
  • Jatakanon A, Lim S, Kharitonov S A, Chung K F, Barnes P J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91–95
  • Jones S L, Kittelson J, Cowan J O, Flannery E M, Hancox R J, McLachlan C R, Taylor D R. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Repir Crit Care Med 2001; 164: 738–743
  • Harkins M S, Fiato K L, Iwamoto G K. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41: 471–476
  • Shaw D E, Berry M A, Thomas M, Green R H, Brightling C E, Wardlaw A J, Pavord I D. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Repir Crit Care Med 2007; 176: 231–237
  • Pijnenburg M W, Baller E M, Lever S, Hop W C, De Jongste J C. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin Exp Allergy 2005; 35: 920–925
  • Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353: 364–369

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.